ABSTRACT
Trade name: Miradon (Schering) Indications: Adjunct in treatment of coronary occlusion, Atrial fibrillation Category: Indanedione oral anticoagulant Half-life: 3-5 days Clinically important, potentially hazardous interactions with: amiodarone,
anabolic steroids, antithyroid agents, barbiturates, bivalirudin, cimetidine, clofibrate, clopidogrel, cyclosporine, delavirdine, dextrothyroxine, disulfiram, fluconazole, glutethimide, imatinib, itraconazole, ketoconazole, metronidazole, miconazole, penicillins, phenylbutazones, piperacillin, quinidine, quinine, rifabutin, rifampin, rifapentine, rofecoxib, salicylates, sulfinpyrazone, sulfonamides, testosterone, thyroid, zileuton
Reactions
Skin Chills
Dermatitis (sic) Ecchymoses Erythema Erythema multiforme Exanthems Exfoliative dermatitis Necrosis Petechiae Purple toe syndrome Urticaria
Hair Hair-alopecia
Other Death
Hypersensitivity Oral ulceration Priapism Stomatitis Stomatodynia
